IFP Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | -$44 | – | 5091 |
|
|
2025
Q1 | – | Hold |
0
| – | -$36 | – | 4047 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4340 |
|
|
2023
Q4 | – | Sell |
-75
| Closed | -$860 | – | 3391 |
|
|
2023
Q3 | $860 | Hold |
75
| – | – | ﹤0.01% | 3030 |
|
|
2023
Q2 | $1.9K | Sell |
75
-2,000
| -96% | -$50.6K | ﹤0.01% | 2897 |
|
|
2023
Q1 | $59.6K | Buy |
2,075
+2,000
| +2,667% | +$57.4K | ﹤0.01% | 1491 |
|
|
2022
Q4 | $2K | Sell |
75
-9
| -11% | -$240 | ﹤0.01% | 4246 |
|
|
2022
Q3 | $3K | Hold |
84
| – | – | ﹤0.01% | 4283 |
|
|
2022
Q2 | $3K | Hold |
84
| – | – | ﹤0.01% | 4049 |
|
|
2022
Q1 | $3K | Buy |
84
+9
| +12% | +$321 | ﹤0.01% | 4049 |
|
|
2021
Q4 | $1K | Buy |
+75
| New | +$1K | ﹤0.01% | 3111 |
|
|
2017
Q3 | – | Sell |
-1,250
| Closed | -$33K | – | 4194 |
|
|
2017
Q2 | $33K | Buy |
1,250
+250
| +25% | +$6.6K | ﹤0.01% | 2241 |
|
|
2017
Q1 | $21K | Buy |
+1,000
| New | +$21K | ﹤0.01% | 2462 |
|
|
2016
Q1 | – | Sell |
-7
| Closed | – | – | 3530 |
|
|
2015
Q4 | $0 | Buy |
+7
| New | – | ﹤0.01% | 3797 |
|